together, these results indicated that IL-2 can induce LAK cells to down-regulate antigen presentation function in a select set of monocytes that have been activated by colony-stimulating factor (GM-CSF and IL-3) but not by gamma interferon. LAK cells may therefore play an important role in regulation of monocytes and their function, depending on their differentiation state.
It is now widely accepted that the majority of interleukin-2 (IL-2)-activated killer (LAK) cells are derived from the large granular lymphocytic (LGL), natural killer (NK) subset of lymphocytes with a CD3-CD16+ CD56+ phenotype (17, 23, 27) . These effector cells have demonstrated broad cytotoxic reactivity against a large variety of tumor cell lines as well as fresh, surgically obtained human tumors (16, 21, 29) . We have recently demonstrated that IL-2-induced human LAK cells, in addition to having tumoricidal activity, have the capacity to lyse autologous and allogeneic monocytes after coculture for 4 to 6 h, as measured by 51Cr release from radiolabeled target cells (12) . The phenotype of the antimonocytic LAK cell fits that of the primary antitumor LAK effector cell. The ability to recognize normal monocytes appears to be specific because granulocytes and nonadherent lymphocytes do not serve as LAK cell targets, whether they are freshly isolated or cultured for 3 to 7 days in vitro. Monocytes, on the other hand, become increasingly more sensitive to LAK cell lysis with in vitro culture. The susceptibility of monocytes to LAK cell lysis may therefore depend on their differentiation state. This inference was further confirmed by the use of monocyte-activating and differentiation factors (2, 3, 13, 14) . Differentiation with granulocytemacrophage colony-stimulating factor (GM-CSF) or IL-3 was found to further enhance monocyte susceptibility. On the other hand, gamma interferon (IFN-y) down-regulated it.
It is also well known that monocytes play an important role as antigen-presenting cells (APC) in initiating an im-* Corresponding author. mune response. Antigen presentation is a sentinel process in the immune system. Monocytes take up antigen, process it, and display an immunogenic fragment to lymphocytes, thereby delivering an activation signal. In addition, monocytes may secrete costimulatory molecules, e.g., IL-1, which are important to the activation process (33) . The biological significance of LAK cell recognition of monocytes is unknown. Our previous study showed that GM-CSFtreated monocytes, after interacting with LAK cells, were significantly suppressed in their ability to inhibit Candida albicans growth (34) . On the basis of our studies, we propose that LAK cells may be involved in some level of regulation of monocyte function. It is possible that the host develops a system for the control of immune homeostasis by specifically eliminating or suppressing monocytes in certain stages of differentiation and activation. Those monocytes which have already accomplished their functions and are no longer required must have a method of elimination from the host system.
In this study, we examined whether autologous LAK cells could modulate monocyte antigen presentation to autologous T cells. Monocytes after treatment with autologous LAK cells were assessed for presentation of both heat-killed intact C. albicans (HK.CA) yeasts and soluble candidal cell wall mannoprotein (MP-F2) to T cells, as measured by [3H]thymidine incorporation during antigen-specific lymphocytic proliferation (1, 28) . Furthermore, the ability of mono-monocytes by these cytokines affected their susceptibility to LAK cells. Any effect should be reflected in the modulation of monocyte antigen presentation capacity to T cells.
MATERIALS AND METHODS
Antigens. Whole Candida yeasts and MP-F2 were used as antigens throughout this study. C. albicans used in this study was a clinical isolate from a patient with chronic mucocutaneous candidiasis and was identified according to the taxonomic criteria established by Lodder (18) . The yeasts were grown by weekly transfer onto fresh Sabouraud agar slants and incubation at 28°C. The colony was collected and washed with phosphate-buffered saline (PBS) and then heated at 100°C for 1 h. C. albicans MP-F2 was kindly provided by Antonio Cassone, Istituto Superiore di Sanita, Rome, Italy, and was obtained after chromatographic separation of a mannoprotein-rich extract as described elsewhere (1, 28 Ca2" and Mg2" at 4°C for 20 to 30 min to detach the adherent monocytes. These monocytes were resuspended in medium and adjusted to the concentrations necessary for the monocyte/T-cell ratios to be used. They were then added to triplicate wells of a 96-well flat-bottom microtiter plate (Costar). These adherent populations were found to be greater than 95% pure monocytes, as judged by WrightGiemsa staining. The trypan blue dye exclusion test for cell viability was also greater than 95%. Human recombinant GM-CSF (generously provided by Immunex Corp., Seattle, Wash.) was added to the monocyte monolayers at 100 U/ml, and the cells were incubated for 4 days at 37°C. In some cases, human recombinant IFN--y or IL-3 (kindly provided by Genentech, South San Francisco, Calif., or Genetics, Inc., Cambridge, Mass., respectively) was used in place of GM-CSF. The cytokines contained less than 0.1 ng of endotoxin per ml, as determined by the Limulus lysate assay (M. A. Biologics).
Treatment of monocytes by LAK cells. After incubation of monocytes with or without cytokines, the culture medium was removed by vigorous washing with warm medium. Immediately thereafter, autologous LAK cells were added to the monocyte monolayers to achieve LAK cell/monocyte ratios of 10:1, 3:1, and 1:1 in 100 pl of medium. The cells were allowed to interact for specified periods of time at 37°C before the nonadherent LAK cells were then gently removed by three washes with warm medium. After complete removal of LAK cells was checked by microscopic examination, the stimulating candidal antigen was added to the monocytes as described below. In some experiments, the monocytes, after treatment with and removal of LAK cells, were incubated for 45 min at 37°C with anti-CD2 plus complement to lyse residual LAK cells. Then, these purified monocytes were stimulated with candidal antigen as described below.
Pulsing of monocytes and T-cell proliferation. For antigen pulsing, monocytes were incubated in the presence of antigen for 2 h, in which the MP-F2 concentration was 100 ,ug/ml and HK.CA was added to achieve a monocyte/HK.CA ratio of 1:10. After being pulsed with antigen, the monocytes were washed at least three times to remove the unbound stimulant. Finally, 105 Percoll gradient-purified T cells were added to triplicate microwells containing control or antigen-pulsed autologous monocytes and were incubated at 37°C in a humidified atmosphere of 5% CO2 in air for 6 days. Cultures were pulsed for the last 18 h with 1 ,uCi of tritiated thymidine per well. The cells were harvested with an automated cell harvester.
The protocol for isolation of LGL, T cells, and monocytes as well as antigen presentation of monocytes to autologous T cells is shown in schematic form in Fig. 1 For membrane IL-1 measurement, the cell pellets were frozen and thawed four times prior to centrifugation at 13,000 x g for 10 min at 4°C. The pelleted membrane fragments were then assessed for the presence of IL-1. IL-la was measured by a competitive form of enzyme-linked immunosorbent assay (ELISA) by ARI, College Park, Md. IL-1,B was measured by a commercial ELISA kit (Cistron Biotechnology, Pine Brook, N.J.).
RNA isolation and Northern (RNA) blot analysis. Autologous LAK cell-treated monocytes were first incubated with anti-CD2 monoclonal antibody plus complement to ensure no T-cell or LAK cell contamination in the monocyte preparations before they were used for RNA isolation as described by Chomczynski and Sacchi (10 After hybridization, the membrane was washed for 5 min in 2x SSC-0.1% SDS-1 mM EDTA at room temperature and for 30 min in lx SSC-0.1% SDS-1 mM EDTA at 45°C with an increase of temperature to 60 to 65°C, depending on the signal. The membrane was then exposed to film with an intensifying screen at -70°C.
Cytotoxic assay against monocytes. Monocytes, cultured for 4 days with GM-CSF, were labeled with 400 ,Ci of sodium [51]chromate (Amersham Corp., Arlington Heights, Ill.) for 2 h in 0.5 ml of medium as described elsewhere (12) . The cells were then washed once and incubated for an additional 30 min in 5 ml of medium. Target cells were then washed twice more and added to IL-2-activated autologous LAK cells at 5 x 103 cells per well in triplicate wells of a 96-well microplate at effector/target ratios of 20:1, 10:1, and 5:1. After 1 to 6 h of incubation at 37°C, the culture supernatants were harvested and counted in a gamma counter. Maximum isotope incorporated was determined by counting target cells alone, and spontaneous release was measured by counting supernatants of target cells incubated with medium alone. Monocyte targets usually had a spontaneous release of 10 to 20% at the 6-h incubation. with monocyte presentation of soluble MP-F2 antigen to T cells.
Effect of LAK cells on optimal and suboptimal monocyte antigen presentation to T cells. To define the optimal number of antigen-pulsed monocytes required for T-cell proliferation, the monocyte/T-cell ratio was varied from 1:2 to 1:16, with the concentration of T cells being held constant. T-cell proliferation was found to be maximal at monocyte/T-cell ratios of 1:2 to 1:4 after culture with either HK.CA-pulsed monocytes (Fig. 3A) or MP-F2-pulsed monocytes (Fig. 3B) for 6 days. The T-cell response was specifically induced by antigen-pulsed monocytes, since T cells alone could not proliferate after pulsing with antigen. The T-cell response to HK.CA was higher, probably because of the larger number of antigenic epitopes on whole yeasts compared with the single mannoprotein moiety. Figure 3 also shows that LAK suppression of intact or soluble antigen presentation by monocytes was still observed at most monocyte/T-cell ratios. In contrast, NK cell-treated monocytes retained both types of antigen-presenting capacity to T cells at either optimal or suboptimal ratios.
Kinetics of LAK cell suppression of monocyte antigen presentation. Initially, 4 h of exposure of monocytes to LAK cells was chosen to examine antigen presentation of monocytes because we consistently detected the ability of LAK cells to lyse monocytes in the 51Cr release assay at 4 to 6 h. However, we also found that LAK cell inhibition of monocyte function occurred earlier than LAK cell-induced cytoplasmic leakage (34) . Because maximal inhibition of antifungal activity in monocytes was seen only after 2 h of exposure to LAK cells, we next determined whether monocyte accessory function, like antifungal activity, was down-regulated prior to cell membrane damage. Therefore, GM-CSF-treated monocytes were incubated with LAK cells for 1 to 6 h at 37°C and washed free of LAK cells before pulsing with antigen. On the other hand, to further confirm that the suppression of monocyte antigen presentation was specifically mediated by LAK cells, the GM-CSF-treated monocytes were also cultured with fresh LGL/NK cells for 1 to 6 h and washed free of LGL/NK cells before assessment of antigen presentation. The monocytes were then cultured for 6 days with autologous T cells. For comparison, LAK cells were also added to 51Cr-labeled GM-CSF-treated monocytes for 1 to 6 h to assess the time required for optimal cytoplasmic leakage. As early as 1 h after incubation of monocytes with LAK cells, significant suppression of antigen presentation was observed (Fig. 4A) . By 4 to 6 h, maximal suppression of monocytes had taken place. On the contrary, incubation of monocytes with fresh LGL NK cells for up to 6 h did not induce a significant level of suppression of antigen presentation by monocytes. With respect to lysis, no significant 51Cr release was detected from the monocytes at 1 or 2 h after exposure to LAK cells, and 4 h or longer was required to achieve high levels of lysis (Fig. 4B) .
Induction of differentiation by various cytokines changes the susceptibility of monocytes to suppression by LAK cells. The effects of IL-3 and IFN--y, which are monocyte-activating and differentiation factors, on monocyte susceptibility to LAK cells were examined. In an earlier study, we found that IL-3 was able to increase the susceptibility of monocytes to LAK cells similarly to GM-CSF (34) . On the other hand, the effect of IFN--y was found to be opposite that of GM-CSF or IL-3. Therefore, after adherent monocytes were cultured with IL-3 or IFN--y for 4 Time of incubation (hrs) FIG. 4 . Kinetics of LAK cell suppression of monocyte antigen presentation. Adherent GM-CSF-treated monocytes (Mo) were exposed to autologous LAK or fresh NK cells for 1 to 6 h at 37°C, the lymphocytes were washed off, and the treated monocytes were pulsed with HK.CA for 2 h before addition of autologous T cells for a further 6-day incubation (A). LAK cells were also added to 51Cr-labeled autologous GM-CSF-treated monocytes for 1 to 6 h at 37°C before the supernatants were collected for measurement of specific lysis (B). presentation was determined by measuring T-cell proliferation. Figure 5 shows that monocytes treated with 100 U of IL-3 per ml were comparable to those treated with 100 U of GM-CSF per ml in their capacity to present antigen to T cells. GM-CSF-treated monocytes were significantly inhibited by LAK cells at ratios of both 10:1 and 3:1 ratios (P < 0.01). In addition, IL-3 had an effect similar to that of GM-CSF on monocytes. Monocytes cultured in IL-3 showed LAK cell susceptibility, which was highly significant at a ratio of 10:1. After LAK cell treatment, IL-3-cultured monocytes showed reduced capacity to present antigen. As with GM-CSF-cultured monocytes, fresh NK cells had little effect on IL-3-cultured monocytes. On the other hand, medium cultured and 100 U of IFN-y per ml rendered monocytes resistant to the inhibitory effect of LAK cells. The level of T-cell proliferation in the presence of IFN--ytreated monocytes exposed to LAK cells was not significantly different from that with the same monocytes not exposed to LAK cells. These results suggest that the two classes of cytokines, colony-stimulating factor (CSF) and IFN-,y, can differentially modulate monocyte susceptibility to suppression of LAK cells. Moreover, we found undifferentiated freshly isolated monocytes to be unaffected by LAK treatment at any LAK cell/monocyte ratio. Figure 6 showed that fresh monocytes without cytokine treatment could not be inhibited by LAK cells to present antigen to T cells.
Effect of LAK cells on IL-1 production from GM-CSFtreated monocytes induced by HK.CA at the protein and mRNA levels. It is an established fact that initiation of the immune response is dependent on the capacity of monocytes to process and present a particular antigen that is displayed on the monocyte surface to be recognized by specific T cells. However, this is not sufficient to fully activate most T cells. It is necessary to generate accessory signals or costimulators, such as IL-1, provided by monocytes during the antigen presentation process (33) . To determine whether the suppression of antigen presentation of monocytes by LAK cells 0.45 = I was also related to this secondary signal, GM-CSF-treated monocytes, cultured with or without LAK cells for 4 h, were pulsed with HK.CA for 48 h before the supernatants were collected for assessment of IL-1. The amounts of both IL-la and IL-113 present in the supernatants were tested by using commercial ELISA kits. Figure 7 clearly shows that generation of both forms of IL-1 in LAK-treated monocytes was significantly suppressed compared with that in untreated monocytes, especially at the high LAK cell/monocyte ratio of 10:1. Because monocytes have been reported to produce and utilize extracellular as well as membrane-bound IL-la for their APC function (11, 31) , monocyte membranes were prepared and the concentration of membrane IL-la induced by HK.CA was assessed. As shown in Fig. 7A , HK.CA could stimulate GM-CSF-cultured monocytes to express membrane IL-la. After LAK cell treatment, however, the levels of membrane IL-lao on these monocytes were significantly reduced.
Furthermore, to confirm that the LAK cell suppression of IL-1 production also occurred at the mRNA level, Northern blot analysis was carried out. Figure 8 shows that GM-CSFtreated monocytes expressed more mRNA for both IL-la and IL-10 than did untreated monocytes. However, the GM-CSF-treated monocytes after exposure to LAK cells had significantly decreased IL-la and IL-1, mRNA expression induced with HK.CA in comparison with monocytes not treated with LAK cells. Almost equivalent amounts of total RNA were isolated from LAK cell-treated and untreated monocytes, indicating that the cells were relatively intact even after LAK cell treatment. Because the RNA was 
DISCUSSION
The central role played by the monocyte in initiation of the primary immune response which results in either production of specific antibodies or cytotoxic T cells is dependent on its ability to process and present antigen associated with self major histocompatibility complex molecules to be recognized by a clonally restricted T-cell receptor complex (8, 25) . In the process, the antigen-stimulated monocyte also generates some costimulators, such as IL-1, which is required in the interaction between APC and the T cell (33) . The molecular basis for this interaction is now understood in some detail. However, the regulation of this process is still unclear.
The factors. Both GM-CSF and IL-3 were equally potent in enhancing the susceptibility of monocytes to LAK cellmediated inhibition. Inhibition of antigen presentation was detected significantly earlier than cell membrane damage in LAK cell-treated monocytes. In fact, it appears that GM-CSF-cultured monocytes are programmed upon contact with LAK cells to lose their function because these monocytes, after 1 h of pretreatment with LAK cells and subsequent removal of the LAK cells, continue to be inhibited in antigen presentation, at a time when no cytoplasmic leakage or cell membrane damage can be detected. In addition to inhibition of antigen presentation, short exposure to LAK cells also down-regulated monocyte production of IL-la and IL-13 at both the protein and mRNA levels.
The effect of IFN--y on monocyte susceptibility was found to be contrary to that of GM-CSF or IL-3 (2, 13). IFN--y was found to protect monocytes from LAK cell suppression of antigen presentation. When monocytes were cultured for 4 days in the presence of 100 U of IFN--y per ml, subsequent exposure to LAK cells did not interfere with their APC function. Other investigators have also found that IFN--y can protect certain tumor cells and fibroblasts from NK/LAK cell lysis (30) . The opposing effects of GM-CSF and IFN-y on monocyte susceptibility to LAK cell functional suppression are equivalent to those previously reported by us on another function of monocytes, i.e., direct antifungal activity against C. albicans (34). Thus, both antimicrobial activity and APC function in monocytes are susceptible to inhibition by LAK cells, depending on the state of activation of the monocytes.
Monocytes responding to IFN--y may serve a slightly different purpose than those responding to GM-CSF, which can be distinctly recognized by LAK cells. Although both cytokines are considered monocyte differentiation and activating factors (9, 20, 22, 32) , there are apparently other properties induced by IFN--y and GM-CSF that differentiate the treated monocytes. These differences become apparent when antimicrobial activity is examined. For example, we have shown that monocytes, placed in culture with medium, progressively lose their ability to inhibit C. albicans growth but that GM-CSF or IL-3 can restore this function in aged monocytes whereas IFN--y cannot (32) . In addition, GM-CSF can activate human monocytes harboring intracellular bacteria, such as Mycobacterium avium-intracellulare, to kill the microbes, yet IFN--y has a detrimental effect on the infected monocytes by increasing the survival of the bacteria within the monocytes (4, 6) . Other data supporting the view that the susceptibility of monocytes to LAK cell downregulation depends on the stage of cell differentiation and maturation come from our finding that freshly isolated monocytes and medium-cultured monocytes had relatively high resistance to LAK cells (2) (3) (4) (12) (13) (14) . The results with fresh and medium-cultured monocytes combined with the opposite effects of IFN--y and GM-CSF or IL-3 on monocytes to LAK cell suppression may reflect an important regulatory pathway that is part of a network of interactive immune cells and cytokines that orchestrate immnunologic events.
Some studies have demonstrated that a cellular immune response to an antigen may also be under the influence of a complex series of specific T cells. For example, contrasuppressor and veto cells have been reported to act upon either the helper T or active cytotoxic T cells in order to maintain immune homeostasis or to control the cytotoxic T-cell reaction in order to down-regulate the cellular immune response to an optimal physiological level. This regulatory process has been intensively studied in the murine system (reviewed in reference 15). However, regulation of the immune response at the APC level is less understood. From the results of this study, we hypothesize that the regulation of LAK cells on monocyte function may represent a system developed to specifically suppress accessory cells at certain stages of activation and differentiation for the control of immune homeostasis. It is possible that the response to a foreign antigen leads to IL-2 induction, followed by LAK cell generation, which might coincide with the induction of GM-CSF at a time that monocytes have presented antigen to T cells and are no longer required. On the other hand, the inhibitory effect of monocytes by LAK cells may serve other purposes. One reported positive effect of LAK cell recognition of monocytes is the elimination of monocytes infected with intracellular pathogens that have established a parasitic state in the phagocytes following ingestion (5, 7). On the negative side, suppression of monocytes by LAK cells could contribute to toxic side effects seen in immunotherapy with IL-2 or LAK cells (19, 24) . It has also been reported that human alveolar macrophages are killed by LAK cells (26) . Lysis of certain types of monocytes or differentiated macrophages by LAK cells therefore could lead to release of inflammatory proteins that could be deleterious to patients receiving continuous IL-2 or LAK cell administration. We are far from a full understanding of the mechanism of LAK cell regulation of monocytes. Further investigation of the LAK cell-monocyte system should yield better insight into the true role of the various cytokines in monocyte differentiation and provide some clues to the significance of LAK cell recognition of a select subset of differentiated monocytes.
